Cannara Biotech Intangible Assets

What does Cannara Biotech do? Cannara Biotech, Inc. generates revenue through its Cannabis operations segment, which includes the cultivation, processing, and sale of dried cannabis and cannabis derivatives for the Canadian market. The company's brand portfolio features Tribal, Nugz, and Orchid CBD, with Orchid CBD specifically targeting the wellness market as a premium CBD-dominant product. The Real estate operations segment involves the management of Farnham and Valleyfield properties, contributing to the company's overall revenue streams. The firm's two mega facilities in Quebec, spanning over 1,650,000 square feet, enable annualized cultivation output of 100,000 kilograms, supporting both product lines and real estate activities. The primary buyers for Cannara's cannabis products are Canadian consumers and businesses within the regulated cannabis market. Tribal and Nugz are positioned as premium cannabis brands, while Orchid CBD serves the wellness segment with its CBD-dominant offerings. Real estate operations focus on leasing and managing the Farnham and Valleyfield buildings, which are part of the company's owned properties. The company's subsidiary structure, including Cannara Biotech (Quebec) Inc. and Cannara Biotech (Valleyfield) Inc.), supports both operational segments without external partnerships or third-party dependencies. Cannara Biotech's revenue model combines direct sales of cannabis products under its brand portfolio with property management income from its real estate holdings. The company's two facilities in Quebec provide the scale necessary for both cultivation and real estate operations, with the Cannabis operations segment driving most of the product-related sales. The Real estate operations segment complements this by generating steady income from the Farnham and Valleyfield properties, which are integral to the company's asset base. Cannara Biotech is one of the most popular companies on Eulerpool.